Sharon Shacham

Insider Reports History

Entity
Individual
Location
C/O Karyopharm Therapeutics Inc., 85 Wells Avenue, Second Floor, Newton, MA
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sharon Shacham:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Karyopharm Therapeutics Inc. Chief Scientific Officer Common Stock 958K $786K $0.82 Mar 29, 2022 Direct
Karyopharm Therapeutics Inc. Chief Scientific Officer Common Stock 714K $585K $0.82 Mar 29, 2022 By Spouse
Karyopharm Therapeutics Inc. Chief Scientific Officer Stock Option (right to buy) 90K Mar 29, 2022 Direct
Acrivon Therapeutics, Inc. Director Stock Option (Right to Buy) 20.3K Jun 20, 2024 Direct

Insider Reports Filed by Sharon Shacham

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRV Acrivon Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
ACRV Acrivon Therapeutics, Inc. Nov 14, 2022 1 $0 4 Nov 16, 2022 Director
ACRV Acrivon Therapeutics, Inc. Nov 9, 2022 0 $0 3 Nov 9, 2022 Director
KPTI Karyopharm Therapeutics Inc. Mar 29, 2022 2 $0 4 Mar 31, 2022 Chief Scientific Officer
KPTI Karyopharm Therapeutics Inc. Feb 28, 2022 4 -$127K 4 Mar 2, 2022 Chief Scientific Officer
KPTI Karyopharm Therapeutics Inc. Feb 17, 2022 2 -$220K 4 Feb 22, 2022 Chief Scientific Officer
KPTI Karyopharm Therapeutics Inc. Feb 7, 2022 2 -$133K 4 Feb 9, 2022 Chief Scientific Officer